392 related articles for article (PubMed ID: 15464016)
1. A review of the mechanisms involved in the acute MDMA (ecstasy)-induced hyperthermic response.
Green AR; O'shea E; Colado MI
Eur J Pharmacol; 2004 Oct; 500(1-3):3-13. PubMed ID: 15464016
[TBL] [Abstract][Full Text] [Related]
2. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").
McNamara R; Kerans A; O'Neill B; Harkin A
Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283
[TBL] [Abstract][Full Text] [Related]
3. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").
Green AR; Mechan AO; Elliott JM; O'Shea E; Colado MI
Pharmacol Rev; 2003 Sep; 55(3):463-508. PubMed ID: 12869661
[TBL] [Abstract][Full Text] [Related]
4. Association of caffeine to MDMA does not increase antinociception but potentiates adverse effects of this recreational drug.
Camarasa J; Pubill D; Escubedo E
Brain Res; 2006 Sep; 1111(1):72-82. PubMed ID: 16889759
[TBL] [Abstract][Full Text] [Related]
5. Interactions between 3,4-methylenedioxymethamphetamine and ethanol in humans and rodents.
Mohamed WM; Hamida SB; de Vasconcelos AP; Cassel JC; Jones BC
Neuropsychobiology; 2009; 60(3-4):188-94. PubMed ID: 19893335
[TBL] [Abstract][Full Text] [Related]
6. Risperidone attenuates and reverses hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats.
Shioda K; Nisijima K; Yoshino T; Kuboshima K; Iwamura T; Yui K; Kato S
Neurotoxicology; 2008 Nov; 29(6):1030-6. PubMed ID: 18722468
[TBL] [Abstract][Full Text] [Related]
7. Effect of 3,4-methylenedioxymethamphetamine ("ecstasy") on body temperature and liver antioxidant status in mice: influence of ambient temperature.
Carvalho M; Carvalho F; Remião F; de Lourdes Pereira M; Pires-das-Neves R; de Lourdes Bastos M
Arch Toxicol; 2002 Apr; 76(3):166-72. PubMed ID: 11967622
[TBL] [Abstract][Full Text] [Related]
8. Effect of repeated ('binge') dosing of MDMA to rats housed at normal and high temperature on neurotoxic damage to cerebral 5-HT and dopamine neurones.
Sanchez V; O'shea E; Saadat KS; Elliott JM; Colado MI; Green AR
J Psychopharmacol; 2004 Sep; 18(3):412-6. PubMed ID: 15358986
[TBL] [Abstract][Full Text] [Related]
9. Effect of ambient temperature and a prior neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA) on the hyperthermic response of rats to a single or repeated ('binge' ingestion) low dose of MDMA.
Green AR; Sanchez V; O'Shea E; Saadat KS; Elliott JM; Colado MI
Psychopharmacology (Berl); 2004 May; 173(3-4):264-9. PubMed ID: 14726996
[TBL] [Abstract][Full Text] [Related]
10. Repeated adolescent 3,4-methylenedioxymethamphetamine (MDMA) exposure in rats attenuates the effects of a subsequent challenge with MDMA or a 5-hydroxytryptamine(1A) receptor agonist.
Piper BJ; Vu HL; Safain MG; Oliver AJ; Meyer JS
J Pharmacol Exp Ther; 2006 May; 317(2):838-49. PubMed ID: 16434566
[TBL] [Abstract][Full Text] [Related]
11. MDMA (3,4-Methylenedioxymethamphetamine) or ecstasy: the neuropsychobiological implications of taking it at dances and raves.
Parrott AC
Neuropsychobiology; 2004; 50(4):329-35. PubMed ID: 15539865
[TBL] [Abstract][Full Text] [Related]
12. Sedative and hypothermic effects of gamma-hydroxybutyrate (GHB) in rats alone and in combination with other drugs: assessment using biotelemetry.
van Nieuwenhuijzen PS; McGregor IS
Drug Alcohol Depend; 2009 Aug; 103(3):137-47. PubMed ID: 19446408
[TBL] [Abstract][Full Text] [Related]
13. Neurotoxicity of Ecstasy metabolites in rat cortical neurons, and influence of hyperthermia.
Capela JP; Meisel A; Abreu AR; Branco PS; Ferreira LM; Lobo AM; Remião F; Bastos ML; Carvalho F
J Pharmacol Exp Ther; 2006 Jan; 316(1):53-61. PubMed ID: 16183702
[TBL] [Abstract][Full Text] [Related]
14. The role of monoamines in the changes in body temperature induced by 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its derivatives.
Docherty JR; Green AR
Br J Pharmacol; 2010 Jul; 160(5):1029-44. PubMed ID: 20590597
[TBL] [Abstract][Full Text] [Related]
15. Neurotoxicity mechanisms of thioether ecstasy metabolites.
Capela JP; Macedo C; Branco PS; Ferreira LM; Lobo AM; Fernandes E; Remião F; Bastos ML; Dirnagl U; Meisel A; Carvalho F
Neuroscience; 2007 Jun; 146(4):1743-57. PubMed ID: 17467183
[TBL] [Abstract][Full Text] [Related]
16. Studies on the effect of MDMA ('ecstasy') on the body temperature of rats housed at different ambient room temperatures.
Green AR; O'Shea E; Saadat KS; Elliott JM; Colado MI
Br J Pharmacol; 2005 Sep; 146(2):306-12. PubMed ID: 15997230
[TBL] [Abstract][Full Text] [Related]
17. Brain hyperthermia induced by MDMA (ecstasy): modulation by environmental conditions.
Brown PL; Kiyatkin EA
Eur J Neurosci; 2004 Jul; 20(1):51-8. PubMed ID: 15245478
[TBL] [Abstract][Full Text] [Related]
18. 3,4-Methylenedioxymethamphetamine- and 8-hydroxy-2-di-n-propylamino-tetralin-induced hypothermia: role and location of 5-hydroxytryptamine 1A receptors.
Rusyniak DE; Zaretskaia MV; Zaretsky DV; DiMicco JA
J Pharmacol Exp Ther; 2007 Nov; 323(2):477-87. PubMed ID: 17702902
[TBL] [Abstract][Full Text] [Related]
19. The dark side of ecstasy: neuropsychiatric symptoms after exposure to 3,4-methylenedioxymethamphetamine.
Karlsen SN; Spigset O; Slørdal L
Basic Clin Pharmacol Toxicol; 2008 Jan; 102(1):15-24. PubMed ID: 18047478
[TBL] [Abstract][Full Text] [Related]
20. MDMA ('Ecstasy') and methamphetamine combined: order of administration influences hyperthermic and long-term adverse effects in female rats.
Clemens KJ; Cornish JL; Li KM; Hunt GE; McGregor IS
Neuropharmacology; 2005 Aug; 49(2):195-207. PubMed ID: 15993443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
